Prospective, Randomized, Open Label Controlled Trial To Evaluate The Safety And Efficacy Of Dexmedetomidine Use Beyond 24 Hours Compared With Midazolam In Children Admitted To Pediatric Intensive Care Unit at King Abdullah Specialist Children Hospital- Ministry of National Guard Health Affairs.

NCT05485519 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

430

Enrollment

OTHER

Sponsor class

Conditions

Dexmedetomidine
Midazolam
Withdrawal Symptoms
Failure of Extubation

Interventions

DRUG: Dexmedetomidine
DRUG: Midazolam

Sponsor

King Abdullah International Medical Research Center